ABSTRACT The effects of short-term administration of verapamil on left ventricular isovolumetric relaxation and early and late diastolic filling dynamics were studied in 10 patients with hypertrophic cardiomyopathy by a combined hemodynamic-ultrasonic technique. Left 1274-1279, 1983. SEVERAL authors' 2 have described a beneficial effect of verapamil on left ventricular diastolic filling and relaxation in patients with hypertrophic cardiomyopathy using different methods after both intravenous and oral administration of the drug.
SEVERAL authors' 2 have described a beneficial effect of verapamil on left ventricular diastolic filling and relaxation in patients with hypertrophic cardiomyopathy using different methods after both intravenous and oral administration of the drug. It has been THERAPY AND PREVENTION-HYPERTROPHIC CARDIOMYOPATHY 
Methods
Patients. Ten patients with hypertrophic cardiomyopathy were studied (five men and five women, mean age 42.2 years) with M mode echocardiography (Echo-cardiovisior; Organon Teknika) and right and left cardiac catheterization (table 1) . The diagnosis of hypertrophic cardiomyopathy was based on combined echocardiographic,4 angiocardiographic, and hemodynamic evaluation. 5 Echocardiography revealed that all patients had hypertrophied nondilated left ventricles without having any other acquired or congenital heart disease.6 All of them had a disproportionate increase of the interventricular septum compared with the left ventricular posterior wall (ratio of interventricular septum to posterior wall B1.3), decreased systolic septal thickening (25% or less), and an abnormal left ventricular shape on two-dimensional echocardiographic imaging. 4 Two-dimensional echocardiography revealed that left ventricular hypertrophy involved substantial portions of both the interventricular septum and left ventricular free wall. 7 Left heart catheterization demonstrated a systolic pressure gradient in five patients at baseline, whereas one patient exhibited a gradient on provocation with the Valsalva maneuver. In the five patients with a systolic pressure gradient at baseline, this gradient increased after provocation by Valsalva maneuver or by atrial pacing.
No provocative tests were performed in one patient with a systolic pressure gradient of 104 mm Hg at baseline. The other patients did not exhibit a gradient at baseline or under provocation.
All drug treatment was discontinued at least 48 hr before our study of the effects of verapamil was undertaken. None of the patients had been treated by verapamil before. All patients were functionally limited at the time of study despite treatment with propranolol (mean dosage 160 + 40 mg/day). Nine of them were in functional class II and one was in functional class III according to criteria of the New York Heart Association.
Selection for the present study was based on lack of improvement of symptoms when treated with propranolol and, therefore, the patients were considered for treatment with verapamil3 or for surgery.
Informed 
Results
The clinical and hemodynamic features of our patients are shown in table 1. Coronary arteriograms were normal in all.
In the five patients with a systolic pressure gradient at baseline (patient Nos. 2, 3, 7, 8, and 9), the magnitude of this gradient did not change in one (patient 3), decreased from 85 mm Hg to 70 mm Hg in patient 2, and decreased from 90 mm Hg to 80 mm Hg in patient 8. The systolic pressure gradient was abolished in pa- Tables 2A and 2B show the results of the pressure-derived contraction and relaxation parameters before and after administration of verapamil. Table 2A shows that left ventricular end-diastolic pressure rose significantly from 21 ± 7 to 23 + 6 mm Hg after verapamil (p < .05). In all patients a slight but significant decrease in systolic systemic pressure (from 120 + 5 to 100 + 5 mm Hg (p < .05) was seen. In addition, left ventricular contractility decreased, as can be seen from the various parameters that were determined: positive left ventricular dP/dt, Vmax, and peak Vce. Table 2B shows that negative left ventricular dP/dt significantly increased (p < .05) after verapamil, and the time constant of relaxation was significantly prolonged. It is also evident from Table 2B that various measurements of the time constant did not change after verapamil. Ultrasound-derived measurements. The echocardiographic measurements before and after verapamil are shown in tables 3A and 3B. It is apparent that left ventricular dimensions and wall thicknesses at both end-diastole and end-systole were not influenced by verapamil. Also, fractional shortening and myocardial thickening were not changed. Although rate of left ventricular lengthening was not changed, peak rate of left ventricular posterior wall thinning decreased significantly from 2.9 ± 1.2 to 2.4 + 1.4 sec-I (p < .05).
Other parameters of diastolic function such as isovolumetric relaxation time, rapid filling period, and t max dD/dt did not change either. None of the pressuredimension loops for the patients shows any change compatible with an improved distensibility at any point in the cardiac cycle. Figure 2 shows a characteristic example of a pressure-dimension loop (patient 8); a leftward or upward diastolic shift compatible with decreased distensibility is shown. Cycle efficiency changed from 68% to 62% (p = NS) after verapamil.
Blood levels of verapamil. In eight patients plasma levels of verapamil were determined, which varied from 90 to 180 ng/ml (therapeutic range, 60 to 140 ng/ ml). In the other two patients, plasma levels of verapamil could not be determined. Discussion It has been suggested that the beneficial effects of verapamil treatment are related to an increased left ventricular filling and improved relaxation resulting in an increased distensibility.1-3 Hanrath et al. I found increased rates of left ventricular lengthening and posterior wall thinning after short-term administration of verapamil. Bonow et al.,2 using radionuclide angiography, showed that peak rate of left ventricular filling increased and time to peak filling was reduced after oral verapamil treatment. fn contrast to these studies, we w demonstrate an improvement in left vc ation nor filling after short-term admin apamil. This was true even though an ( was achieved as demonstrated by the c tricular systolic pressures and contrac During early diastole, when left v sures and left ventricular dimensions rapidly, both rates of relaxation and re were further impaired. Moreover, left diastolic pressure increased without a ventricular dimension, indicating dec bility.
These effects cannot be completely patient selection because the relevant supported by a concomitant increase in the time constant of isovolumetric relaxation and a decrease in neg-CIRCULATION a n ative left ventricular dP/dt. Because, to our knowledge, this is the first study that has used this method to study the effects of verapamil in patients with hypertrophic cardiomyopathy, no comparison is available with respect to the relationship of the time constant of relaxation and rates of posterior wall thinning.
Our results are probably not entirely comparable with results described after oral verapamil treatment,2 because in the present short-term study a significant drop in left ventricular contractility occurred that was not present in other studies.'-3 Tissue distribution of verapamil after oral treatment is probably different from that after short-term administration. Thus, although we reached therapeutic plasma levels in our patients, these levels probably bear no relationship to plasma levels reached after long-term oral treatment.
The heterogeneous aspects of hypertrophic cardiomyopathy, both in its clinical and hemodynamic expression as in the presence of left ventricular hypertrophy in various areas of the left ventricle7 and the presence of variations in regional systolic wall thickening in normal subjects of 10% or more'6 make it more difficult to compare our results with findings of others.
Finally, it should be remembered that before verapamil became available, an increased distensibility was found that explained the symptomatic improvement of patients with hypertrophic cardiomyopathy treated with fl-blocking drugs. But a recent study that used methods comparable to ours have convincingly shown that diastolic pressure-volume relationships were not influenced by f-blockade and that the earlier observations therefore were not correct. '7 Despite the limitations of the study as described above, several of our findings support our belief that the area of left ventricular myocardium we studied is involved in the hypertrophic (or cardiomyopathic) process. Individual values of end-diastolic posterior wall thickness as determined by M mode echocardiography varied between 13 and 18 mm and were significantly larger than normal values. Furthermore, two-dimensional echocardiographic analysis with a recently evolved method described by Maron et al.7 showed that all our patients had extensive left ventricular hypertrophy, which could have been underestimated by M mode echocardiography. clinical observations that potential complications after oral verapamil treatment might occur due to systemic hypotension and decreased contractility.'8 Extrapolation of our results to clinical management should be carried out with caution because of the short-term nature of this study.
